,32 Furthermore, recurrent mutations across cancer types and patients, including highly recurrent promoter mutations in the TERT and PLEKHS1 genes, overlap non-B DNA motifs33, 34, 35 and likely predispose these regions to increased mutagenesis. This evidence concerns the gene TERT and cancer.